SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $492 | +18.8% | 51,800 | 0.0% | 0.00% | – |
| Q1 2024 | $414 | -93.5% | 51,800 | 0.0% | 0.00% | – |
| Q4 2023 | $6,397 | -65.7% | 51,800 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $18,648 | -66.7% | 51,800 | -18.0% | 0.00% | -66.7% |
| Q4 2022 | $55,995 | -43.4% | 63,200 | 0.0% | 0.01% | -94.3% |
| Q3 2022 | $99,000 | -43.1% | 63,200 | 0.0% | 0.16% | +618.2% |
| Q2 2022 | $174,000 | -99.9% | 63,200 | 0.0% | 0.02% | -87.1% |
| Q1 2022 | $119,448,000 | +40528.6% | 63,200 | 0.0% | 0.17% | +709.5% |
| Q4 2021 | $294,000 | – | 63,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 2,186,520 | $38,526,000 | 10.61% |
| Cormorant Asset Management, LP | 1,945,334 | $34,277,000 | 4.56% |
| Aisling Capital LLC | 1,703,855 | $30,022,000 | 4.47% |
| Wildcat Capital Management, LLC | 736,012 | $12,968,000 | 4.44% |
| ACUTA CAPITAL PARTNERS, LLC | 212,402 | $3,743,000 | 2.31% |
| Healthcare Value Capital, LLC | 50,000 | $881,000 | 0.92% |
| EAM Investors, LLC | 249,028 | $4,388,000 | 0.51% |
| TFS CAPITAL LLC | 150,812 | $2,657,000 | 0.26% |
| GAGNON SECURITIES LLC | 11,001 | $194,000 | 0.08% |
| Granite Investment Partners, LLC | 43,861 | $772,000 | 0.07% |